Literature DB >> 29633896

THERPA: A small molecule database related to prion protein regulation and prion diseases progression.

Sol Moe Lee1,2, Wonseok Lee2, Yeong Seon Lee1, Jin-Soo Yoo3, Soo-Jung Park3, Heebal Kim2, Su Yeon Kim1.   

Abstract

Prion diseases are fatal neurodegenerative disorders that affect humans and animals. Although various small molecules have been evaluated for application in the treatment of prion diseases, none have been shown to be efficacious. Expanding our knowledge of these molecules is important for understanding of the complex mechanisms of prion diseases. To improve access to the scattered information on small molecules related to prion diseases, we built a database of therapeutic molecules associated with prion diseases (THERPA, therpa.pythonanywhere.com). THERPA includes 119 small molecules and their 283 relationships with prion diseases. THERPA is an interactive visual database and useful for improving search efficiency which can help researchers identify intrinsic small molecules that can be used for developing therapeutics for prion diseases.

Entities:  

Keywords:  Database; Prion; Prion diseases; THERPA; small molecules

Mesh:

Substances:

Year:  2018        PMID: 29633896      PMCID: PMC6016511          DOI: 10.1080/19336896.2018.1461519

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  16 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  COMPARISON OF CHLOROQUINE, QUINACRINE (ATABRINE), AND QUININE IN THE TREATMENT OF ACUTE ATTACKS OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN).

Authors:  T N Pullman; B Craige; A S Alving; C M Whorton; R Jones; L Eichelberger
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

3.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 4.  Role of copper in prion diseases: deleterious or beneficial?

Authors:  Lorena Varela-Nallar; Alfonso González; Nibaldo C Inestrosa
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  Copper chelation delays the onset of prion disease.

Authors:  Einar M Sigurdsson; David R Brown; Muhammad A Alim; Henrieta Scholtzova; Richard Carp; Harry C Meeker; Frances Prelli; Blas Frangione; Thomas Wisniewski
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

6.  Role of copper and manganese in prion disease progression.

Authors:  Gerda Mitteregger; Stefan Korte; Mehdi Shakarami; Jochen Herms; Hans A Kretzschmar
Journal:  Brain Res       Date:  2009-07-25       Impact factor: 3.252

7.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

8.  Disruption of copper homeostasis due to a mutation of Atp7a delays the onset of prion disease.

Authors:  Owen M Siggs; Justin T Cruite; Xin Du; Sophie Rutschmann; Eliezer Masliah; Bruce Beutler; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

9.  Copper binding to PrPC may inhibit prion disease propagation.

Authors:  Nuha Hijazi; Yuval Shaked; Hana Rosenmann; Tamir Ben-Hur; Ruth Gabizon
Journal:  Brain Res       Date:  2003-12-12       Impact factor: 3.252

10.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

Authors:  Stephen J Wroe; Suvankar Pal; Durrenajaf Siddique; Harpreet Hyare; Rebecca Macfarlane; Susan Joiner; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; Patricia Hewitt; John Collinge
Journal:  Lancet       Date:  2006-12-09       Impact factor: 79.321

View more
  1 in total

1.  Transcriptomic analysis identifies novel potential biomarkers and highlights cilium-related biological processes in the early stages of prion disease in mice.

Authors:  Yong-Chan Kim; Byung-Hoon Jeong
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.